The MHA Keystone Center launched the MHA Keystone: Pain Management collaborative in 2015 to address the growing concerns surrounding opioid overuse in the hospital setting, develop opioid prescribing guidelines and distribute resources for patients. The initiative aimed to improve pain management, decrease opioid use, and educate patients about safe pain management. It received national recognition for its progress toward those goals which resulted in improved patient care and reduced healthcare costs.
According to a 1997 study, the costs associated with over-sedated patients was more than $5,000 per occurrence, as it results in respiratory depression, prolonged recovery and length of stay, and other clinical interventions. To address that issue, specific interventions of the MHA Keystone: Pain Management collaborative included a focus on patient screenings to determine opioid naivety or tolerance; risk and sedation assessments; and improvement of opioid prescription practices.
From 2015-2016, the MHA Keystone Center reported a nearly 50 percent decrease in the number of patients who required reversal agents after being treated with IV opioids. This results in better outcomes and care for patients and nearly $12.97 million in cost savings in the state. Based on these outcomes, the MHA Keystone: Pain Management collaborative received national recognition in 2016.
Other efforts from the MHA Keystone Center include:
- Developing patient educational materials around opioids in partnership with its Patient Family Advisory Committee and clinical experts
- Working with partner organizations under the MHA Keystone Hospital Engagement Network and the Great Lakes Partnership for Patients Hospital Improvement Innovation Network to decrease the use of opioids and instances in opioid-related adverse events in hospitals in Michigan, Illinois and Wisconsin.
- Participating in national opioid task forces by several MHA and MHA Keystone Center staff members.